CompletedNot Applicable

Patient-Reported Quality of Life in Patients With an Implantable-Cardioverter Defibrillator - A Cross-Sectional Observational Study

Belgium731 participantsStarted 2024-11-01

Plain-language summary

Patients at risk for life-threatening arrhythmias are eligible for the implantation of an implantable cardioverter-defibrillator (ICD), which has repeatedly shown improved survival. However, living with an ICD may pose several challenges and affect quality of life (QoL). This prospective cross-sectional observational cohort studies will provide detailed insights in patient-reported QoL. The aim is to study the QoL perspective of patients who have an ICD, including physical and emotional health; ICD acceptance; concerns of ICD patients with regard to physical and sexual activity.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age ≥ 18 years of age * Patients with any type of ICD followed in UZ Leuven * Willing and able to provide signed written informed consent Exclusion Criteria: * Patients who are hospitalized * Patients with a mental disability * Patients already included in another interventional study

What they're measuring

ICD acceptance assessed using the Florida Patient Acceptance Survey (FPAS)

Timeframe: Cross-sectional at time of inclusion

Trial details

NCT IDNCT06654232

SponsorUniversitaire Ziekenhuizen KU Leuven

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-10-31

View on ClinicalTrials.gov More Implantable Cardioverter Defibrillator (ICD) trials